Hemab Therapeutics Holdings, Inc. (COAG)

Last Closing Price: 41.22 (2026-09-17)

Days Sales in Receivables (Quarterly)

Days Sales in Receivables: The average number of days it takes to collect outstanding receivable amounts from customers. Calculated as: Number of Days in Period / Receivable Turnover

Hemab Therapeutics Holdings, Inc. (COAG) Days Sales in Receivables data is not available.

Figures for fiscal quarter ending 2026-06-30
Income Statement Financials
--
$-24.15M
--
--
$26.08M
$-26.08M
$2.03M
$-24.05M
$-24.05M
$-24.15M
$-24.15M
$-24.15M
$-24.15M
$-26.08M
$-26.00M
30.11M
30.11M
$-0.80
$-0.80
Balance Sheet Financials
$464.00M
$0.60M
$3.78M
$467.78M
$12.94M
--
$0.57M
$13.51M
$454.27M
$454.27M
$454.27M
46.71M
Cash Flow Statement Financials
$-44.22M
$-123.28M
$317.12M
$87.97M
$237.37M
$149.39M
$3.33M
--
--
Fundamental Metrics & Ratios
35.85
--
--
--
--
--
--
--
--
--
--
$-44.36M
--
--
--
--
--
--
Days Sales in Receivables
--
-5.32%
-5.32%
-5.16%
-5.32%
$9.73
$-1.47
$-1.47